Pregnancy is a dynamic state that requires increased nutrient intakes in order to support the growing fetus, placenta and maternal tissues, and hence a successful pregnancy outcome. Although maternal micronutrient deficiencies during pregnancy are often associated with pregnancy complications, as well as adverse fetal growth and development, evidence to support routine vitamin and mineral supplementation is relatively scarce. This review summarises existing evidence and special considerations regarding folic acid, vitamin B 12 , vitamin D, calcium, zinc, iron, selenium and iodine supplementation on pregnancy outcomes. Current practice recommendations are for routine supplementation of folic acid and iodine, but recommendations regarding other vitamins and minerals are based on an individualised approach in pregnancy, with supplementation restricted to women with insufficient dietary intakes or established deficiencies. This review aims to support pharmacists in evaluating the appropriateness of various individual and multicomponent vitamin and mineral supplements and providing balanced and up-to-date information to women who are either planning pregnancy or are already pregnant.
INTRODUCTION
Pregnancy is a dynamic state characterised by major changes to maternal physiology and anatomy in order to accommodate the growth of the fetus and placenta. Adjustments in nutrient metabolism are key to supporting not only the fetus, but also the mother. It is important that pregnant women maintain adequate levels of essential vitamins and minerals. Collectively known as micronutrients, these dietary components support virtually all aspects of cellular and metabolic activity, including cell proliferation, apoptosis and differentiation, as well as tissue growth and homeostasis.
1 Deficiencies in certain micronutrients, either through reduced dietary intake or impaired intestinal absorption or excretion, can have dire consequences on pregnancy outcome. 2 Pregnancy complications, including pre-eclampsia, gestational hypertension, intrauterine growth restriction (IUGR) and preterm birth, affect one in five first-pregnancies and predict lifelong morbidity and mortality for both mother and child. 3 The cause of many of these complications is largely unknown. However, there is abundant literature looking at associations between pregnancy complications and deficiencies in vitamin D, folate, vitamin B 12 , iodine, iron, zinc and selenium. 1 Severe micronutrient deficiencies are more common in developing countries, 4 particularly in populations who avoid meat and/or dairy products, as well as those with diets high in unrefined grains and legumes that contain phytates and polyphenols, which limit micronutrient absorption. 5 However, suboptimal micronutrient status may still affect the risk of adverse pregnancy outcomes because many physiological pathways can be disrupted by even the smallest perturbations in micronutrient homeostasis. Thus, governing bodies like the Institute of Medicine 5 and the National Health and Medical
Research Council (NHMRC) of Australia 6 recommend pregnant women increase their daily intake of most micronutrients (Table 1) . This review summarises a number of recent metaanalyses of the use of supplements taken during pregnancy containing specific micronutrients, namely folic acid, vitamin D, calcium and trace minerals iron, iodine, zinc and selenium, for the prevention of pregnancy complications. Most of these micronutrients are included in the leading Australian pregnancy multivitamin formulations (Table 2) . Thus, there is increased interest in determining their utility in improving pregnancy outcome.
FOLIC ACID
Folic acid is synthetic vitamin B 9 that is converted to folate in the body. Its metabolism is essential in numerous biological pathways, including the 1-carbon metabolic pathway, in which it, together with vitamin B 12 , facilitates the transfer of a methyl group for numerous biosynthetic reactions. 7 It has long been known that supplementation with folic acid in the periconceptional and gestational periods prevents the development of a number of major congenital malformations, particularly neural tube defects (NTD) because folate is critically important during periods of rapid growth. 8, 9 Most notably, folic acid administration prior to and during early pregnancy has been demonstrated to significantly reduce the risk of NTD (Risk Ratio (RR) 0.31; 95% confidence interval (CI) 0.17-0.58). 10 For this reason, it is recommended that all women should take at least 0.4 mg daily for a minimum of 1 month before conception and for the first 12 weeks of pregnancy. 6 Special considerations and recommendations for higher doses of folic acid are provided in Table 3 . Given not all pregnancies are planned, many women may not even realise that they are pregnant until late in the first trimester. In an effort to reduce the risk of folate deficiencies among women of childbearing age, all wheat flour used for making bread in Australia has been fortified with folic acid since September 2009. Despite benefits with regard to congenital malformations, a meta-analysis of 31 trials of folic acid supplementation throughout pregnancy found no conclusive evidence of benefit with respect to any pregnancy outcomes. 11 This was despite the fact that supplementation with folic acid improves predelivery maternal folate levels (RR 0.38; 95% CI 0.25-0.59). 11 None of the studies included in that analysis assessed pre-eclampsia or hypertensive disorders of pregnancy as key outcomes, and thus further trials are required to determine the effects of folic acid supplementation throughout pregnancy on other prevalent pregnancy complications. 21 Despite such findings from observational studies, a recent meta-analysis of randomised controlled trials investigating vitamin D determined that evidence to date is insufficient to guide clinical or policy recommendations regarding supplementation in pregnancy. 22 Despite no high-quality evidence supporting a reduction in adverse pregnancy outcomes following Furthermore, low maternal serum vitamin D concentrations are correlated with low neonatal levels. This is important because vitamin D deficiency in the neonate and the infant has been associated with impaired skeletal development and an increased incidence of hypocalcaemic seizures. 23 Although routine screening and supplementation with vitamin D is not currently recommended, women should be assessed for vitamin D deficiency based on established risk factors (Table 3) and offered treatment as appropriate.
VITAMIN D

CALCIUM
During pregnancy, maternal calcium homeostasis is integral to supporting fetal bone health and development. 25 This is largely dependent on maternal vitamin D status and the vitamin D metabolic pathway, which, during pregnancy, maintains adequate transfer of calcium to the growing fetus. 26 Currently, it is recommended that pregnant women consume >1000 mg calcium in order to meet increased fetal calcium requirements. 6 Hypocalciuria (reduced calcium in the urine) has been associated with pre-eclampsia, [27] [28] [29] and measuring urinary calcium to creatinine ratio in early pregnancy has been suggested as a possible predictor of pre-eclampsia. 30 For this reason, calcium supplementation is recommended as a preventative measure for pre-eclampsia, particularly in groups of women who avoid dairy products (Table 3) . [31] [32] [33] [34] A recent meta-analysis on the use of high- 
IRON
Anaemia, as a result of iron deficiency, is highly prevalent in women worldwide. 36 Iron is required by numerous proteins that participate in many cellular functions, including oxygen transport, antioxidant defences and DNA synthesis. 37 Thus, reducing the incidence of iron deficiency in pregnant women is a key goal for many health organisations. Iron deficiency in pregnancy has been associated with increasing perinatal morbidity and mortality 36, 38 and it is recommended that pregnant women increase their daily iron intake to support increased requirements. 6 However, routine supplementation of iron is not recommended and no clear benefit for a reduction in adverse perinatal outcomes has been observed, 39 despite iron supplementation reducing the risk of maternal anaemia and the development of iron deficiency. There is evidence for possible reductions in the risk of preterm birth or delivering a low birth weight infant in settings where nutritional intake is poor and the risk of anaemia or adverse perinatal outcomes is much higher, such as in developing nations. 40 Therefore, the relevance of these findings and potential Table 3 and can be used to guide screening practices. Specific guidelines for the management of anaemia in pregnancy have been published elsewhere. 41 
IODINE
Iodine is an essential component of thyroid hormones, which are necessary for brain development in utero. Since the implementation of universal fortification of salt with iodine in bread making, severe iodine deficiency is rare. However, mild to moderate deficiency still persists. 43 Irreversible damage to a child's normal physical growth and mental development can be attributed to maternal iodine deficiency during pregnancy, as well as iodine deficiency in early childhood. Thus, iodine supplementation with 150 micrograms daily is recommended for both pregnant and lactating women and mandatory in areas of regional deficiency (Table 3) . 6 Despite consistent reports that iodine is integral to supporting fetal neurodevelopment, there is inconclusive evidence to show any beneficial support to pregnancy complications, primarily due to a lack of randomised controlled trails that have assessed outcomes such as preterm birth or pre-eclampsia. 44 These trials have largely focused on neurodevelopment, so there is still no understanding of the effects of supplementation on birth weight or prematurity.
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ZINC AND SELENIUM
Trace minerals including zinc and selenium are present in minute amounts within the body but are integral to cellular function and tissue physiology. 45 Zinc is an essential component for numerous antioxidant enzymes, metalloenzymes, zinc-binding factors and zinc transporters. 46 Although severe zinc deficiency is relatively scarce, mild to moderate zinc deficiency is estimated to be common throughout the world 47 and, given the diverse range of biological functions involving zinc, it is not surprising that zinc deficiency is associated with adverse pregnancy outcome and poor fetal development. 48 Analysis of 21 randomised control trials and 17 000 women found that zinc supplementation in pregnancy, compared with no treatment or placebo, reduced the risk of preterm delivery (RR 0.86; 95% CI 0.75-0.97) but did not affect low birth weight delivery (RR 0.93; 95% CI 0.78-1.12) or preeclampsia (RR 0.83; 95% CI 0.64-1.08). 49 As with zinc, selenium is an antioxidant, important in supporting immune function and reducing cellular stress. Selenium deficiency in pregnancy has been associated with miscarriage, pre-eclampsia and fetal growth restriction, 50, 51 and selenium supplementation has beneficial effects on hypertension. 52 Thus, the NHMRC recommends an additional 10-15 micrograms/day selenium for pregnant women, 6 and most pregnancy supplements contain selenium. 53 Despite the inclusion of selenium in pregnancy supplements, there have been very few trials of selenium supplementation in pregnancy, [54] [55] [56] and therefore whether selenium supplementation is beneficial to pregnancy outcome is uncertain.
USE OF MULTIVITAMINS
In an effort to address potential individual micronutrient deficiencies, many women take complex pregnancy multivitamins. Despite high-frequency use and widespread marketing and promotion, there is a lack of evidence that routine supplementation with multivitamins or supplements containing multiple micronutrients either in pre-or periconception is beneficial to pregnancy outcome. 57, 58 In many cases, supplementation with such multivitamins may provide amounts of various vitamins and minerals above what is actually needed. Such supplements may not be completely without harm. For example, although supplementation with vitamin C alone does not appear to be beneficial, 59 supplementation with combined vitamins C and E from 12 to 18 weeks gestation has been shown to increase the risk of fetal loss or perinatal death. 60 Furthermore, vitamin A is a teratogen, with high intake during pregnancy being associated with an increased risk of congenital malformations. 61, 62 Therefore, limits to the amount of vitamin A pregnant women should take are advised. A lack of high-quality, large, randomised controlled trials significantly limits our ability to evaluate the benefits, or potential harms, of routine vitamin and mineral supplementation in pregnancy. Therefore, some degree of caution regarding widespread routine supplementation practices is warranted.
CONCLUSIONS
At present, only folic acid and iodine are recommended for routine supplementation for all women. Intake of other vitamins and minerals, such as iron, calcium and vitamin D, are dependent on a woman's abilities to meet recommended dietary intakes based on nutritional intake alone, or on identified nutritional deficiencies. Although multivitamin use is common in pregnancy, there is a lack of data supporting widespread use. Pharmacists should be aware of special considerations regarding vitamin and mineral supplementation in pregnancy and be prepared to provide balanced and up-to-date information to women.
